PBIO (Pressure BioSciences) Days Payable: 595.42 (As of Jun. 2024)


PBIO Pressure BioSciences Inc PBIO
12 GF Score
Price $0.00
View Full Analysis

What is Pressure BioSciences Days Payable?

Pressure BioSciences PBIO -71.43% 12 Days Payable is 595.42 as of Jun. 2024. GuruFocus rates PBIO with a GF Score™ of 12/100.

Pressure BioSciences's average Accounts Payable for the three months ended in Jun. 2024 was $2.47 Mil. Pressure BioSciences's Cost of Goods Sold for the three months ended in Jun. 2024 was $0.38 Mil. Hence, Pressure BioSciences's Days Payable for the three months ended in Jun. 2024 was 595.42.

The historical rank and industry rank for Pressure BioSciences's Days Payable or its related term are showing as below:

PBIO's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 67.83
* Ranked among companies with meaningful Days Payable only.

Pressure BioSciences's Days Payable increased from Jun. 2023 (298.43) to Jun. 2024 (595.42). It may suggest that Pressure BioSciences delayed paying its suppliers.

Pressure BioSciences Days Payable Historical Data

* Premium members only.

The historical data trend for Pressure BioSciences's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences Days Payable Chart

Pressure BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 224.89 497.10 251.86 105.57 303.19

Pressure BioSciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 298.43 393.49 326.50 736.07 595.42

PBIO vs EMED, CUTRQ, MHTX: Days Payable Comparison

For the Medical Devices subindustry, Pressure BioSciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pressure BioSciences Days Payable vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pressure BioSciences's Days Payable distribution charts can be found below:

* The bar in red indicates where Pressure BioSciences's Days Payable falls into.


PBIO
12GF Score
Pressure BioSciences Inc PBIO
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pressure BioSciences Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Pressure BioSciences's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.637 + 1.32) / 2 ) / 1.178*365
=0.9785 / 1.178*365
=303.19

Pressure BioSciences's Days Payable for the quarter that ended in Jun. 2024 is calculated as:

Days Payable (Q: Jun. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2024 ) + Accounts Payable (Q: Jun. 2024 )) / count ) / Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=( (2.439 + 2.494) / 2 ) / 0.378*365 / 4
=2.4665 / 0.378*365 / 4
=595.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 595.42 mean?
Pressure BioSciences (PBIO) has a Days Payable of 595.42 as of Jun. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pressure BioSciences and its competitors.
Is Pressure BioSciences' Days Payable too high?
Pressure BioSciences' current Days Payable is 595.42. The Medical Devices & Instruments industry median Days Payable is 67.83. Pressure BioSciences' value of 595.42 is 777.8% above this industry median. Overall, Pressure BioSciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pressure BioSciences' Days Payable compare to EMED and CUTRQ?
Pressure BioSciences' Days Payable of 595.42 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 67.83. Pressure BioSciences' value of 595.42 is 777.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.83, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pressure BioSciences's current Days Payable of 595.42 is 777.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Pressure BioSciences and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pressure BioSciences's current Days Payable is 595.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pressure BioSciences stock overvalued right now?
Pressure BioSciences (PBIO) has a current Days Payable of 595.42. The current Days Payable is 595.42 and 777.8% above the Medical Devices & Instruments industry median of 67.83. Pressure BioSciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Pressure BioSciences (PBIO), the current Days Payable is 595.42 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pressure BioSciences Business Description

Address 14 Norfolk Avenue, South Easton, MA, USA, 02375
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
12GF Score

Get the complete analysis for PBIO

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price